Aerovate Therapeutics declares special cash dividend, estimated $2.40 per share
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 09 2025
0mins
Should l Buy ?
Special Cash Dividend Announcement: Aerovate Therapeutics has declared a special cash dividend of $69.6 million, approximately $2.40 per share, in connection with its merger with Jade Biosciences, payable to stockholders of record as of April 25.
Dividend Characterization: The cash dividend is expected to be classified as a return of capital rather than a traditional dividend, as Aerovate does not anticipate having current or accumulated earnings and profits.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
